CDKN2A and renal cell carcinoma: Analysis of the pooled OR showed that p16INK4A and p14ARF promoter methylation were significantly higher in patients with RCC than in control subjects, suggesting that p16INK4A and p14ARF inactivation via promoter methylation may play an important role in the tumorigenesis of RCC.